VanEck Associates’s MiMedx Group MDXG Stock Holding History

VanEck Associates’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,120	Closed	-$31K	–	1430
2025 Q1	$31K	Hold	4,120	–	–	﹤0.01%	1319
2024 Q4	$40K	Buy	+4,120	New	+$32.1K	﹤0.01%	1304

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

VanEck Associates's MDXG Position: Q2 2025 in Review

VanEck Associates sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 4,120 shares — an estimated $31K sold.

VanEck Associates first reported a position in MDXG in Q4 2024 and held it in 2 quarters. The position peaked at $40K in Q4 2024. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

VanEck Associates reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
VanEck Associates sold 4,120 MiMedx Group shares in Q2 2025, an estimated $31K.
VanEck Associates first reported a position in MiMedx Group in Q4 2024 and held it in 2 quarters.
VanEck Associates's MiMedx Group position peaked at $40K in Q4 2024.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on VanEck Associates's 13F filing for Q2 2025, filed 14 Aug 2025.